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Survivin functions as an apoptosis 
inhibitor and a regulator of cell 
division during development and 
tumorigenesis. Since survivin is a 
highly relevant target for tumor 
therapy, we investigated whether 
interference with it’s dynamic 
cellular localization represents a 
novel strategy to inhibit survivin’s 
cancer promoting functions. We 
confirmed survivin overexpression 
in head and neck as well as in 
colorectal cancers and identified 
an evolutionary conserved Crm1-
dependent nuclear export signal 
(NES) in survivin. Importantly, nuclear export was required for 
survivin mediated protection 
against chemo- and radiotherapy-
induced apoptosis by securing 
efficient interference with 
cytoplasmic caspases. In dividing 
cells, the NES was required for 
tethering of survivin and of the 
survivin/Aurora-B kinase complex 
to the mitotic machinery, which 
was inevitable for proper cell 
division. The clinical relevance of 
our findings was supported by 
showing that preferential nuclear 
localization of survivin correlated 
with enhanced survival in a cohort 
of colorectal cancer patients. 
Targeting survivin’s nuclear export 
by the application of NES-specific 
antibodies promoted its nuclear 
accumulation and inhibited its 
cytoprotective function. We here 
show that nuclear export is 
essential for the tumor promoting 
activities of survivin and 
encourage the identification of 
chemical inhibitors to specifically 
interfere with survivin’s nuclear 
export as a novel class of 
anticancer therapeutics.
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